Scroll Back to Top

Study number 8533-669

1 Night, 10 Follow up Visits & 3 Calls

Dates

Jul 29 2024-Oct 08 2024

Location

Madison, Wisconsin

Age

18-65

Gender

Males and Females

Compensation

$6,805

Group

2 or 5

Study Details

Fortrea Madison, WI is recruiting for:
- Healthy Adults, age 18-65
- Body Mass Index between 18-34 
- Study involves 1 overnight stay, 10 follow-up visits and 3 phone calls
- Compensation up to $6,805 may be provided for time and participation
- Refer a friend to receive $400 per qualified referral

 

 

Additional Details

Mirikizumab (the study drug) is an investigational drug that has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis (a bowel disease that causes inflammation in the digestive tract). The study drug is also being developed for the potential treatment of autoimmune diseases (a condition in which the immune system mistakenly attacks the body) and Crohn’s disease (a bowel disease that affects the lining of the digestive tract). 

Group 2:

Check-In: Jul 29
Check-Out: Jul 30

Outpatient Visits: Aug 1, 3, 6, 9, 13, 20, 27

Phone Call: Sep 3

Outpatient Visit: Sep 10

Phone Call: Sep 17

Outpatient Visit: Sep 24

Phone Call: Oct 1

Outpatient Visit: Oct 8

 

Group 5:

Check-In: Aug 12
Check-Out: Aug 13

Outpatient Visits: Aug 15, 17, 20, 23, 27, Sep 3, 10

Phone Call: Sep 17

Outpatient Visit: Sep 24

Phone Call: Oct 1

Outpatient Visit: Oct 8

Phone Call: Oct 15

Outpatient Visit: Oct 22

 

BMI Calculator

Weight

Height

Feet Inches